Magenta Therapeutics – pharmaceutical daily

May 6, 2020 Off

Avrobio, Magenta team up to test targeted antibody-drug conjugate for lentiviral gene therapies

Collaboration focuses on advancing innovation with antibody-drug conjugate (ADC)-based conditioning for lentiviral gene therapies Under the collaboration, AVROBIO and Magenta…

June 24, 2019 Off

Magenta Therapeutics Appoints Anne McGeorge to Board of Directors

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem…

April 29, 2019 Off

Magenta Therapeutics Launches Proposed Public Offering

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of…